XML 73 R52.htm IDEA: XBRL DOCUMENT v3.6.0.2
ALLIANCES (Lilly) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Alliances Statement [Line Items]                      
Net product sales                 $ 17,702 $ 14,045 $ 11,660
Alliance revenues                 1,725 2,515 4,219
Total Revenues $ 5,243 $ 4,922 $ 4,871 $ 4,391 $ 4,287 $ 4,069 $ 4,163 $ 4,041 19,427 16,560 15,879
Cost of products sold - Amortization of intangible asset                 178 183 286
Royalties                 (618) (293) (192)
Divestiture loss                 564 194 564
Erbitux [Member]                      
Alliances Statement [Line Items]                      
Total Revenues                   501 723
Lilly [Member]                      
Alliances Statement [Line Items]                      
Net product sales                   492 691
Alliance revenues                   9 32
Total Revenues                   501 723
Cost of products sold - Distribution fees and royalties                   204 287
Cost of products sold - Amortization of intangible asset                   11 37
Cost of products sold - Cost of product supply                   46 $ 69
Royalties                 (246) (70)  
Divestiture loss                   $ 171  
Lilly [Member] | Erbitux [Member] | North America [Member]                      
Alliances Statement [Line Items]                      
Distribution fee, percentage of net sales         39.00%         39.00%  
Divestiture non-cash charge                   $ 171  
Royalty sales threshold - 2015                 165    
Royalty sales threshold - 2016                 650    
Royalty sales threshold - 2017                 650    
Royalty sales threshold - 2018                 480    
Royalties                 $ 227 56  
Lilly and Merck KGaA [Member] | Erbitux [Member] | Japan [Member]                      
Alliances Statement [Line Items]                      
Percentage share of pre-tax profit/loss received from the net sales of a collaboration partner to be shared further equally with another collaboration partner. 50.00%               50.00%    
Merck KGaA [Member] | Erbitux [Member] | Japan [Member]                      
Alliances Statement [Line Items]                      
Royalties                 $ 19 $ 14  
Maximum [Member] | Lilly [Member] | Erbitux [Member] | North America [Member]                      
Alliances Statement [Line Items]                      
Royalty rate on net sales                 38.00%    
Minimum [Member] | Lilly [Member] | Erbitux [Member] | North America [Member]                      
Alliances Statement [Line Items]                      
Royalty rate on net sales                 20.00%